Updated Jul 16, 2026
Garfield Alastair has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $85K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | RYTM | RHYTHM PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 2.1K | $110.41 | $237K |
| 2026-07-02 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 4.4K | — | |
| 2026-02-03 | RYTM | RHYTHM PHARMACEUTICALS, INC. | F — Tax withholding / forfeiture | 2.0K | $108.99 | $221K |
| 2026-02-03 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 6.7K | — | |
| 2025-07-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | S — Open-market sale | 6 | $64.60 | $388 |
| 2025-07-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | S — Open-market sale | 1.3K | $64.81 | $85K |
| 2025-07-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | M — Option exercise | 4.4K | — |
Garfield Alastair is a corporate insider — currently tracked as Chief Scientific Officer of RHYTHM PHARMACEUTICALS, INC. (RYTM). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($85K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Garfield Alastair profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.